TOBRAMYCIN

TOBRAMYCIN was reported 23590 times

TOBRAMYCIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1580 0.2900
1 CYSTIC FIBROSIS LUNG 33 0.2578
2 CYSTIC FIBROSIS 1283 0.2315
3 CYSTIC FIBROSIS RESPIRATORY INFECTION SUPPRESSION 161 0.1803
4 CYSTIC FIBROSIS RELATED DIABETES 26 0.1781
5 CHOROIDITIS 64 0.1711
6 INFECTIVE KERATITIS 12 0.1690
7 INFECTIVE EXACERBATION OF BRONCHIECTASIS 46 0.1498
8 PSEUDOMONAS BRONCHITIS 10 0.1449
9 ACQUIRED FACTOR V DEFICIENCY 14 0.1273
10 TRACHEOSTOMY INFECTION 15 0.1230
11 PULMONARY FUNCTION TEST DECREASED 426 0.0972
12 PELVIC KIDNEY 10 0.0862
13 DISTAL INTESTINAL OBSTRUCTION SYNDROME 29 0.0861
14 KERATITIS FUNGAL 17 0.0817
15 ANTIBIOTIC LEVEL ABOVE THERAPEUTIC 32 0.0788
16 LUNG INFECTION PSEUDOMONAL 42 0.0753
17 VENTILATION PERFUSION MISMATCH 20 0.0712
18 KERATITIS BACTERIAL 11 0.0675
19 PSEUDOMONAS INFECTION 554 0.0645
20 PANCREATIC INSUFFICIENCY 23 0.0637
21 CORNEAL INFILTRATES 20 0.0637
22 PSEUDOMONAS TEST POSITIVE 52 0.0635
23 BURKHOLDERIA CEPACIA COMPLEX INFECTION 18 0.0629
24 SLE ARTHRITIS 16 0.0563
25 CORNEAL THINNING 14 0.0545
26 INCREASED VISCOSITY OF BRONCHIAL SECRETION 34 0.0533
27 CORNEAL NEOVASCULARISATION 13 0.0526
28 OTOTOXICITY 96 0.0519
29 TRACHEITIS 37 0.0486
30 PNEUMONIA PSEUDOMONAL 73 0.0476
31 VITAMIN K DEFICIENCY 19 0.0473
32 SPUTUM INCREASED 102 0.0471
33 ELBOW DEFORMITY 16 0.0462
34 RESPIRATORY TRACT IRRITATION 47 0.0450
35 CORNEAL EPITHELIUM DEFECT 26 0.0448
36 MYCOBACTERIUM CHELONAE INFECTION 33 0.0447
37 CORNEAL PERFORATION 27 0.0428
38 BACTERIAL DISEASE CARRIER 30 0.0412
39 FORCED EXPIRATORY VOLUME DECREASED 115 0.0406
40 RESPIRATORY TRACT INFECTION BACTERIAL 19 0.0382
41 SPUTUM ABNORMAL 24 0.0362
42 RETINOPATHY OF PREMATURITY 20 0.0361
43 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 33 0.0356
44 CHOLANGITIS INFECTIVE 9 0.0338
45 RESTRICTIVE CARDIOMYOPATHY 10 0.0330
46 HYPOPYON 27 0.0326
47 TRICHOSPORON INFECTION 13 0.0321
48 BRONCHIECTASIS 211 0.0313
49 TRACHEAL HAEMORRHAGE 11 0.0312
50 HYPOTONY OF EYE 13 0.0310
51 BRONCHIAL SECRETION RETENTION 38 0.0298
52 CLUBBING 12 0.0294
53 MYCOBACTERIUM ABSCESSUS INFECTION 21 0.0294
54 LUNG TRANSPLANT 103 0.0291
55 LUNG TRANSPLANT REJECTION 19 0.0288
56 BRONCHIAL WALL THICKENING 19 0.0264
57 INCREASED BRONCHIAL SECRETION 66 0.0258
58 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 13 0.0254
59 GLOMERULONEPHRITIS MEMBRANOPROLIFERATIVE 13 0.0248
60 PULMONARY FUNCTION TEST ABNORMAL 37 0.0237
61 OVERLAP SYNDROME 16 0.0229
62 STENOTROPHOMONAS INFECTION 31 0.0228
63 CORNEAL OPACITY 30 0.0220
64 NASAL INFLAMMATION 23 0.0218
65 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 49 0.0198
66 SPUTUM CULTURE POSITIVE 16 0.0197
67 VESTIBULAR DISORDER 24 0.0196
68 RHONCHI 26 0.0188
69 LUNG INFECTION 287 0.0185
70 APLASTIC ANAEMIA 96 0.0184
71 CONJUNCTIVAL HYPERAEMIA 64 0.0179
72 PSOAS ABSCESS 11 0.0177
73 SINUS OPERATION 42 0.0176
74 CONJUNCTIVAL OEDEMA 18 0.0175
75 SERRATIA INFECTION 13 0.0174
76 PNEUMONIA STAPHYLOCOCCAL 34 0.0172
77 HYPERBILIRUBINAEMIA NEONATAL 10 0.0172
78 BRONCHITIS BACTERIAL 13 0.0172
79 ULCERATIVE KERATITIS 47 0.0171
80 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 120 0.0167
81 SPUTUM RETENTION 16 0.0161
82 KERATITIS 48 0.0158
83 CHRONIC RESPIRATORY FAILURE 19 0.0157
84 HAEMOPTYSIS 438 0.0157
85 RHINOVIRUS INFECTION 61 0.0157
86 ENDOPHTHALMITIS 94 0.0157
87 SPUTUM DISCOLOURED 144 0.0152
88 RENAL TUBULAR INJURY 18 0.0148
89 SCEDOSPORIUM INFECTION 10 0.0142
90 RENAL TUBULAR NECROSIS 137 0.0140
91 ENTEROVIRUS INFECTION 12 0.0139
92 LINEAR IGA DISEASE 23 0.0138
93 STAPHYLOCOCCUS TEST POSITIVE 29 0.0137
94 ANTIBIOTIC THERAPY 13 0.0133
95 DEVICE RELATED THROMBOSIS 13 0.0132
96 ACINETOBACTER INFECTION 14 0.0128
97 OCULAR HYPERTENSION 24 0.0124
98 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 13 0.0122
99 PAINFUL RESPIRATION 29 0.0120
100 CULTURE POSITIVE 10 0.0120
101 REBOUND ACID HYPERSECRETION 36 0.0119
102 NEPHROGENIC ANAEMIA 55 0.0119
103 MYCOTIC ALLERGY 10 0.0117
104 CORNEAL OEDEMA 26 0.0116
105 CHEST INJURY 24 0.0116
106 HYPERPARATHYROIDISM SECONDARY 29 0.0116
107 HEART TRANSPLANT 10 0.0110
108 CARBON DIOXIDE INCREASED 15 0.0110
109 BRONCHOSPASM 156 0.0109
110 RESPIRATORY SYMPTOM 31 0.0109
111 PATHOGEN RESISTANCE 99 0.0109
112 TOTAL LUNG CAPACITY DECREASED 17 0.0106
113 DISEASE COMPLICATION 48 0.0105
114 DEAFNESS NEUROSENSORY 34 0.0103
115 JAW FRACTURE 22 0.0102
116 PULMONARY HAEMORRHAGE 79 0.0101
117 NEPHROPATHY TOXIC 108 0.0096
118 APHONIA 132 0.0094
119 CHRONIC SINUSITIS 35 0.0093
120 TOXIC ANTERIOR SEGMENT SYNDROME 10 0.0092
121 UNDERWEIGHT 18 0.0091
122 BRONCHIAL DISORDER 14 0.0090
123 CONJUNCTIVITIS ALLERGIC 13 0.0088
124 CREPITATIONS 26 0.0087
125 ASPERGILLUS INFECTION 57 0.0087
126 RASH MORBILLIFORM 24 0.0086
127 MYCOBACTERIUM AVIUM COMPLEX INFECTION 23 0.0086
128 RUBBER SENSITIVITY 13 0.0085
129 PRODUCTIVE COUGH 396 0.0083
130 CENTRAL VENOUS CATHETERISATION 25 0.0083
131 LUNG DISORDER 404 0.0082
132 DRUG RESISTANCE 211 0.0082
133 FEBRILE CONVULSION 10 0.0082
134 LUNG ABSCESS 17 0.0081
135 PNEUMOTHORAX 127 0.0080
136 DISCHARGE 11 0.0079
137 CORNEAL DISORDER 17 0.0077
138 BACTERIAL TEST POSITIVE 17 0.0076
139 OBLITERATIVE BRONCHIOLITIS 10 0.0076
140 RESPIRATION ABNORMAL 52 0.0075
141 SWELLING OF EYELID 47 0.0075
142 STEATORRHOEA 20 0.0075
143 ERYTHEMA OF EYELID 40 0.0074
144 PANCREATIC FAILURE 13 0.0073
145 DRUG LEVEL INCREASED 121 0.0073
146 PARAINFLUENZAE VIRUS INFECTION 11 0.0072
147 INTRAOCULAR PRESSURE INCREASED 92 0.0072
148 PSEUDOMEMBRANOUS COLITIS 16 0.0072
149 BRONCHIAL OBSTRUCTION 10 0.0071
150 BLOOD CULTURE POSITIVE 21 0.0070
151 TRACHEOSTOMY 10 0.0070
152 MYCOBACTERIAL INFECTION 12 0.0070
153 SECRETION DISCHARGE 87 0.0069
154 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 16 0.0069
155 EYE OEDEMA 17 0.0069
156 RESPIRATORY TRACT INFECTION VIRAL 16 0.0069
157 HOSPITALISATION 1053 0.0068
158 RALES 39 0.0067
159 WEIGHT ABNORMAL 16 0.0067
160 EMERGENCY CARE 20 0.0066
161 METAMORPHOPSIA 12 0.0065
162 GASTROSTOMY 10 0.0064
163 RESPIRATORY SYNCYTIAL VIRUS INFECTION 56 0.0064
164 GASTROINTESTINAL TUBE INSERTION 16 0.0064
165 EYELID PAIN 13 0.0064
166 TOXIC EPIDERMAL NECROLYSIS 97 0.0064
167 PNEUMONIA BACTERIAL 58 0.0063
168 MECHANICAL VENTILATION 12 0.0063
169 SOCIAL PROBLEM 26 0.0063
170 STAPHYLOCOCCAL INFECTION 206 0.0062
171 ILL-DEFINED DISORDER 377 0.0062
172 VOCAL CORD DISORDER 12 0.0061
173 PULMONARY CONGESTION 80 0.0061
174 EXOPHTHALMOS 13 0.0060
175 INFECTION 873 0.0060
176 END STAGE RENAL DISEASE 110 0.0060
177 DEAFNESS BILATERAL 10 0.0059
178 LOWER RESPIRATORY TRACT CONGESTION 10 0.0059
179 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 45 0.0058
180 BRONCHITIS CHRONIC 14 0.0057
181 INFUSION SITE DISCHARGE 10 0.0057
182 VASCULITIS 65 0.0056
183 PARANASAL SINUS HYPERSECRETION 21 0.0055
184 ANGLE CLOSURE GLAUCOMA 14 0.0055
185 MULTIPLE-DRUG RESISTANCE 17 0.0055
186 BLOOD IMMUNOGLOBULIN E INCREASED 13 0.0054
187 BACTERIAL INFECTION 99 0.0053
188 WHEEZING 313 0.0053
189 PORTAL HYPERTENSION 16 0.0052
190 DYSPHONIA 303 0.0052
191 OBSTRUCTIVE AIRWAYS DISORDER 57 0.0051
192 INFUSION SITE BRUISING 11 0.0051
193 RESPIRATORY DISORDER 151 0.0050
194 EXERCISE TOLERANCE DECREASED 29 0.0050
195 STREPTOCOCCAL INFECTION 28 0.0050
196 WALKING AID USER 33 0.0050
197 EYELID OEDEMA 58 0.0050
198 GASTROINTESTINAL OBSTRUCTION 12 0.0050
199 HYPERCAPNIA 15 0.0050
200 UVEITIS 67 0.0049
201 DEAFNESS 129 0.0049
202 EYE PAIN 277 0.0049
203 STAPHYLOCOCCAL SEPSIS 24 0.0049
204 ORAL CANDIDIASIS 64 0.0049
205 ADENOVIRUS INFECTION 14 0.0048
206 EYELIDS PRURITUS 15 0.0048
207 ACUTE KIDNEY INJURY 736 0.0048
208 PNEUMONIA 1529 0.0047
209 OXYGEN SATURATION DECREASED 265 0.0047
210 FOREIGN BODY SENSATION IN EYES 30 0.0047
211 UPPER RESPIRATORY TRACT INFECTION 217 0.0047
212 HEPATOSPLENOMEGALY 12 0.0047
213 BREATH SOUNDS ABNORMAL 23 0.0047
214 CONJUNCTIVITIS 86 0.0046
215 COUGH 1300 0.0046
216 OXYGEN CONSUMPTION INCREASED 11 0.0046
217 OCULAR DISCOMFORT 51 0.0045
218 NASAL POLYPS 22 0.0045
219 RESPIRATORY RATE DECREASED 14 0.0045
220 RESPIRATORY TRACT INFECTION 116 0.0044
221 GASTROINTESTINAL HYPOMOTILITY 10 0.0044
222 VIRAL INFECTION 147 0.0044
223 SYSTEMIC CANDIDA 11 0.0044
224 TINNITUS 198 0.0043
225 DISTURBANCE IN SOCIAL BEHAVIOUR 10 0.0042
226 FIBROSIS 13 0.0042
227 HORDEOLUM 18 0.0042
228 CHRONIC KIDNEY DISEASE 314 0.0041
229 VISUAL ACUITY REDUCED 137 0.0041
230 CLOSTRIDIUM TEST POSITIVE 9 0.0041
231 PNEUMONIA FUNGAL 16 0.0041
232 RESPIRATORY RATE INCREASED 36 0.0041
233 CONCOMITANT DISEASE AGGRAVATED 25 0.0040
234 HAEMODIALYSIS 34 0.0040
235 GRANULOMA 14 0.0040
236 CREATININE RENAL CLEARANCE DECREASED 16 0.0040
237 EYE INFECTION 45 0.0040
238 PLEURITIC PAIN 11 0.0040
239 LUNG INFILTRATION 35 0.0040
240 INFUSION SITE HAEMORRHAGE 13 0.0039
241 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 20 0.0039
242 AORTIC ANEURYSM 30 0.0039
243 LUNG CONSOLIDATION 11 0.0039
244 STAPHYLOCOCCAL BACTERAEMIA 17 0.0039
245 ARTHRITIS BACTERIAL 16 0.0039
246 INCREASED UPPER AIRWAY SECRETION 20 0.0039
247 DIASTOLIC DYSFUNCTION 12 0.0039
248 TUBULOINTERSTITIAL NEPHRITIS 72 0.0038
249 BLOOD CREATININE DECREASED 12 0.0038
250 PHOTOPHOBIA 71 0.0038
251 PNEUMONIA VIRAL 12 0.0038
252 VASCULAR DEVICE INFECTION 17 0.0037
253 MACULAR OEDEMA 21 0.0037
254 HYPERTRANSAMINASAEMIA 26 0.0037
255 ATELECTASIS 36 0.0037
256 PROTEIN TOTAL DECREASED 14 0.0037
257 PARANASAL SINUS DISCOMFORT 14 0.0037
258 ACUTE RESPIRATORY FAILURE 71 0.0037
259 PROTEINURIA 70 0.0037
260 RESPIRATORY DISTRESS 101 0.0037
261 EYE DISCHARGE 38 0.0037
262 RESPIRATORY TRACT CONGESTION 58 0.0036
263 DRUG PRESCRIBING ERROR 70 0.0036
264 SINUS DISORDER 72 0.0036
265 VITREOUS HAEMORRHAGE 10 0.0036
266 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 62 0.0036
267 CANDIDA INFECTION 61 0.0036
268 RHINITIS ALLERGIC 16 0.0036
269 CHEST DISCOMFORT 366 0.0036
270 RESPIRATORY FAILURE 259 0.0035
271 PATENT DUCTUS ARTERIOSUS 14 0.0035
272 ENTEROCOCCAL INFECTION 17 0.0035
273 BLOOD CHLORIDE DECREASED 9 0.0035
274 BLEPHARITIS 14 0.0035
275 OCULAR HYPERAEMIA 165 0.0035
276 HAEMOTHORAX 10 0.0034
277 PULMONARY PAIN 10 0.0034
278 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 58 0.0034
279 HYPERNATRAEMIA 17 0.0034
280 HYPOXIA 120 0.0034
281 DERMATITIS EXFOLIATIVE 17 0.0034
282 BACTERIAL SEPSIS 11 0.0034
283 RENAL FAILURE ACUTE 143 0.0034
284 SINUS CONGESTION 45 0.0033
285 MALNUTRITION 37 0.0033
286 PERIORBITAL OEDEMA 17 0.0033
287 VENOOCCLUSIVE LIVER DISEASE 16 0.0032
288 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 168 0.0032
289 CONDITION AGGRAVATED 975 0.0032
290 CLOSTRIDIUM DIFFICILE COLITIS 34 0.0032
291 INFUSION SITE SWELLING 20 0.0032
292 SEPTIC SHOCK 137 0.0031
293 CONJUNCTIVAL HAEMORRHAGE 12 0.0031
294 MULTI-ORGAN FAILURE 54 0.0031
295 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 80 0.0031
296 SEASONAL ALLERGY 44 0.0031
297 OSTEOPENIA 47 0.0031
298 FAILURE TO THRIVE 16 0.0031
299 LACRIMATION INCREASED 93 0.0031
300 EYE PRURITUS 103 0.0031
301 GRAFT VERSUS HOST DISEASE 22 0.0031
302 HEPATOMEGALY 30 0.0030
303 PROTHROMBIN TIME PROLONGED 18 0.0030
304 PERIORBITAL SWELLING 17 0.0030
305 TRANSPLANT REJECTION 24 0.0030
306 LOWER RESPIRATORY TRACT INFECTION 136 0.0030
307 VIRAL UPPER RESPIRATORY TRACT INFECTION 14 0.0029
308 ENTEROCOLITIS 17 0.0029
309 INSURANCE ISSUE 45 0.0029
310 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
311 RENAL FAILURE 389 0.0029
312 SMALL INTESTINAL OBSTRUCTION 36 0.0029
313 RASH MACULO-PAPULAR 65 0.0029
314 BRONCHOPNEUMONIA 10 0.0029
315 INFLUENZA 321 0.0029
316 EYE SWELLING 106 0.0028
317 NEPHROLITHIASIS 130 0.0028
318 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 136 0.0028
319 CARDIOPULMONARY FAILURE 11 0.0028
320 GENERAL PHYSICAL CONDITION ABNORMAL 19 0.0028
321 UPPER-AIRWAY COUGH SYNDROME 23 0.0028
322 ASTHMA 315 0.0028
323 KLEBSIELLA INFECTION 14 0.0028
324 INTESTINAL ISCHAEMIA 15 0.0027
325 RETINAL DETACHMENT 25 0.0027
326 BLOOD UREA INCREASED 45 0.0027
327 EOSINOPHILIA 47 0.0027
328 HAEMOLYTIC ANAEMIA 24 0.0027
329 DIALYSIS 38 0.0027
330 HEARING IMPAIRED 16 0.0027
331 NYSTAGMUS 14 0.0026
332 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 16 0.0026
333 ORGANISING PNEUMONIA 13 0.0026
334 INCORRECT DRUG ADMINISTRATION RATE 11 0.0026
335 EMPHYSEMA 26 0.0026
336 TACHYPNOEA 35 0.0026
337 ESCHERICHIA INFECTION 21 0.0026
338 RESPIRATORY ACIDOSIS 10 0.0025
339 LEUKOCYTOSIS 46 0.0025
340 BLOOD ALBUMIN DECREASED 20 0.0025
341 DYSPNOEA 1427 0.0025
342 HYPERBILIRUBINAEMIA 26 0.0025
343 POST PROCEDURAL COMPLICATION 48 0.0025
344 C-REACTIVE PROTEIN ABNORMAL 16 0.0025
345 CANDIDIASIS 10 0.0025
346 ACIDOSIS 19 0.0025
347 ORGAN FAILURE 10 0.0025
348 THROAT IRRITATION 111 0.0025
349 PANCREATIC DISORDER 12 0.0024
350 RENAL INJURY 72 0.0024
351 INFLAMMATORY MARKER INCREASED 12 0.0024
352 PHARYNGITIS 30 0.0024
353 INTESTINAL OBSTRUCTION 91 0.0024
354 BRONCHITIS 178 0.0024
355 HYPOVOLAEMIA 14 0.0024
356 ASPIRATION 26 0.0024
357 HYPOACUSIS 102 0.0024
358 PATHOLOGICAL FRACTURE 12 0.0024
359 BACTERAEMIA 28 0.0024
360 UMBILICAL HERNIA 11 0.0024
361 PULMONARY HYPERTENSION 49 0.0024
362 RENAL IMPAIRMENT 197 0.0023
363 PURULENT DISCHARGE 10 0.0023
364 EYE IRRITATION 134 0.0023
365 OFF LABEL USE 2021 0.0023
366 EYE INFLAMMATION 22 0.0023
367 BLOOD ALKALINE PHOSPHATASE INCREASED 56 0.0023
368 STEVENS-JOHNSON SYNDROME 50 0.0022
369 RETINAL HAEMORRHAGE 16 0.0022
370 FOOD POISONING 12 0.0022
371 RHINITIS 18 0.0022
372 SINUSITIS 228 0.0022
373 PRODUCT USE ISSUE 418 0.0022
374 PRODUCT DOSE OMISSION 145 0.0022
375 ANURIA 19 0.0022
376 TRANSFUSION 23 0.0022
377 EJECTION FRACTION DECREASED 34 0.0022
378 EAR DISORDER 10 0.0022
379 AUTISM SPECTRUM DISORDER 12 0.0022
380 MUCOSAL INFLAMMATION 57 0.0022
381 CLOSTRIDIUM DIFFICILE INFECTION 47 0.0022
382 ACUTE RESPIRATORY DISTRESS SYNDROME 38 0.0021
383 PERIPHERAL VASCULAR DISORDER 11 0.0021
384 HAEMATOCRIT DECREASED 42 0.0021
385 ENCEPHALOPATHY 52 0.0021
386 BLOOD CREATININE INCREASED 138 0.0021
387 EAR INFECTION 56 0.0021
388 COAGULOPATHY 35 0.0021
389 FUNGAL INFECTION 70 0.0021
390 OLIGURIA 13 0.0021
391 ABNORMAL SENSATION IN EYE 9 0.0021
392 OROPHARYNGEAL PAIN 193 0.0021
393 EPSTEIN-BARR VIRUS INFECTION 13 0.0021
394 ABNORMAL FAECES 17 0.0021
395 PRODUCT ADMINISTRATION INTERRUPTED 16 0.0020
396 NEPHROPATHY 19 0.0020
397 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
398 SINUS HEADACHE 12 0.0020
399 MUCOUS STOOLS 10 0.0020
400 LOW BIRTH WEIGHT BABY 16 0.0020
401 WEIGHT FLUCTUATION 21 0.0020
402 GASTROENTERITIS VIRAL 36 0.0020
403 SEPSIS 222 0.0020
404 DRUG INTOLERANCE 192 0.0020
405 PYREXIA 686 0.0020
406 MYASTHENIA GRAVIS 16 0.0020
407 DEATH 1706 0.0020
408 DRY THROAT 20 0.0020
409 RENAL FAILURE CHRONIC 15 0.0019
410 PULMONARY MASS 29 0.0019
411 SCOLIOSIS 12 0.0019
412 BRONCHOPULMONARY ASPERGILLOSIS 15 0.0019
413 PULMONARY THROMBOSIS 21 0.0019
414 MALABSORPTION 10 0.0019
415 MULTIPLE ALLERGIES 15 0.0019
416 LIVER FUNCTION TEST INCREASED 41 0.0019
417 MOUTH HAEMORRHAGE 14 0.0019
418 BLOOD PRESSURE SYSTOLIC INCREASED 37 0.0019
419 ELECTROLYTE IMBALANCE 22 0.0019
420 NASAL CONGESTION 110 0.0019
421 HERPES SIMPLEX 12 0.0018
422 NEUROTOXICITY 32 0.0018
423 LIGAMENT SPRAIN 18 0.0018
424 ANEURYSM 9 0.0018
425 TREATMENT NONCOMPLIANCE 98 0.0018
426 ANHEDONIA 47 0.0018
427 TOXIC SKIN ERUPTION 18 0.0018
428 INFLAMMATION 92 0.0018
429 DYSPNOEA EXERTIONAL 67 0.0018
430 PERONEAL NERVE PALSY 10 0.0018
431 DERMATITIS CONTACT 20 0.0018
432 EYE MOVEMENT DISORDER 12 0.0018
433 UNRESPONSIVE TO STIMULI 45 0.0017
434 VITAMIN D DEFICIENCY 17 0.0017
435 BRAIN OEDEMA 22 0.0017
436 BLOOD BILIRUBIN INCREASED 47 0.0017
437 HYPERKALAEMIA 61 0.0017
438 PANCREATITIS ACUTE 39 0.0017
439 PRODUCT USE IN UNAPPROVED INDICATION 429 0.0017
440 PULMONARY FIBROSIS 33 0.0017
441 DECUBITUS ULCER 14 0.0017
442 SPINAL OSTEOARTHRITIS 15 0.0017
443 CARDIOMEGALY 21 0.0017
444 HAEMODYNAMIC INSTABILITY 13 0.0017
445 SINUS TACHYCARDIA 24 0.0017
446 PHARYNGITIS STREPTOCOCCAL 18 0.0017
447 NEUTROPHIL COUNT INCREASED 17 0.0017
448 RIB FRACTURE 34 0.0017
449 MENINGITIS 11 0.0016
450 LIQUID PRODUCT PHYSICAL ISSUE 12 0.0016
451 TERMINAL STATE 11 0.0016
452 DISSEMINATED INTRAVASCULAR COAGULATION 23 0.0016
453 CHOKING SENSATION 9 0.0016
454 BODY TEMPERATURE DECREASED 16 0.0016
455 GALLBLADDER DISORDER 29 0.0016
456 RHINORRHOEA 104 0.0016
457 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 88 0.0016
458 URINE OUTPUT DECREASED 14 0.0016
459 WEIGHT DECREASED 447 0.0016
460 ASPARTATE AMINOTRANSFERASE INCREASED 85 0.0016
461 ALANINE AMINOTRANSFERASE INCREASED 98 0.0016
462 CHOLECYSTITIS ACUTE 9 0.0016
463 MALAISE 691 0.0016
464 QUALITY OF LIFE DECREASED 21 0.0016
465 PNEUMONIA ASPIRATION 39 0.0016
466 DEVICE RELATED INFECTION 24 0.0016
467 OROPHARYNGEAL DISCOMFORT 14 0.0015
468 PLEURAL EFFUSION 94 0.0015
469 WHITE BLOOD CELL COUNT INCREASED 59 0.0015
470 SPLENOMEGALY 18 0.0015
471 PETECHIAE 16 0.0015
472 TREATMENT FAILURE 127 0.0015
473 RENAL DISORDER 71 0.0015
474 ECONOMIC PROBLEM 23 0.0015
475 BLOOD CALCIUM DECREASED 17 0.0015
476 FEBRILE NEUTROPENIA 100 0.0015
477 GASTROINTESTINAL DISORDER 134 0.0015
478 POST-TRAUMATIC STRESS DISORDER 10 0.0015
479 SENSORY LOSS 12 0.0015
480 SLEEP DISORDER 105 0.0015
481 THERAPY INTERRUPTED 106 0.0015
482 DECREASED ACTIVITY 16 0.0015
483 FACE OEDEMA 25 0.0015
484 HYPERSENSITIVITY 275 0.0015
485 SHOCK 34 0.0015
486 KIDNEY INFECTION 29 0.0015
487 PERICARDIAL EFFUSION 34 0.0015
488 CYANOSIS 23 0.0015
489 PAROSMIA 11 0.0015
490 CHEST PAIN 268 0.0014
491 MENTAL STATUS CHANGES 40 0.0014
492 PRESYNCOPE 35 0.0014
493 BLOOD SODIUM DECREASED 27 0.0014
494 EYE DISORDER 47 0.0014
495 EYE HAEMORRHAGE 19 0.0014
496 CARDIOMYOPATHY 21 0.0014
497 PAPULE 10 0.0014
498 BLOOD POTASSIUM INCREASED 23 0.0014
499 LETHARGY 81 0.0014
500 VITAMIN D DECREASED 12 0.0014
501 GASTROOESOPHAGEAL REFLUX DISEASE 113 0.0014
502 PRODUCT DISTRIBUTION ISSUE 13 0.0014
503 GAMMA-GLUTAMYLTRANSFERASE INCREASED 31 0.0014
504 PNEUMONITIS 38 0.0014
505 DRUG TOXICITY 19 0.0014
506 CARDIOGENIC SHOCK 20 0.0014
507 TRICUSPID VALVE INCOMPETENCE 11 0.0014
508 OSTEOMYELITIS 25 0.0014
509 BONE DISORDER 25 0.0014
510 HEPATIC ENZYME INCREASED 93 0.0014
511 ASCITES 40 0.0014
512 MUSCULOSKELETAL CHEST PAIN 21 0.0014
513 BLOOD PRESSURE DIASTOLIC DECREASED 10 0.0014
514 GENERAL PHYSICAL HEALTH DETERIORATION 156 0.0013
515 MUSCULOSKELETAL DISCOMFORT 23 0.0013
516 UNEVALUABLE EVENT 101 0.0013
517 AUTOIMMUNE DISORDER 13 0.0013
518 CHOKING 26 0.0013
519 MITRAL VALVE INCOMPETENCE 15 0.0013
520 PANCYTOPENIA 74 0.0013
521 CONTRAINDICATED PRODUCT ADMINISTERED 40 0.0013
522 TACHYCARDIA 117 0.0013
523 COMPLICATION ASSOCIATED WITH DEVICE 19 0.0013
524 RESPIRATORY DEPRESSION 16 0.0013
525 INFUSION SITE ERYTHEMA 11 0.0013
526 TRANSAMINASES INCREASED 29 0.0013
527 NIGHT SWEATS 42 0.0013
528 NASOPHARYNGITIS 240 0.0013
529 BLINDNESS 53 0.0013
530 INTENTIONAL DOSE OMISSION 37 0.0013
531 INTERVERTEBRAL DISC DEGENERATION 12 0.0013
532 BRAIN INJURY 13 0.0013
533 HYPERSOMNIA 37 0.0013
534 LIVER DISORDER 57 0.0013
535 IMMUNODEFICIENCY 19 0.0013
536 PSYCHOLOGICAL TRAUMA 11 0.0013
537 MUSCLE STRAIN 11 0.0013
538 THROMBOCYTOPENIA 141 0.0013
539 RENAL CYST 10 0.0013
540 ABSCESS 20 0.0013
541 CELLULITIS 63 0.0012
542 SNEEZING 28 0.0012
543 TENDERNESS 13 0.0012
544 SURGERY 73 0.0012
545 HEART RATE INCREASED 123 0.0012
546 HEPATIC STEATOSIS 23 0.0012
547 SHOCK HAEMORRHAGIC 10 0.0012
548 THERAPY CESSATION 63 0.0012
549 GASTROINTESTINAL INFECTION 11 0.0012
550 CATARACT 73 0.0012
551 DRUG INTERACTION 194 0.0012
552 THERAPY CHANGE 12 0.0012
553 MENTAL DISORDER 53 0.0012
554 HYPOCALCAEMIA 23 0.0012
555 ARTHROPOD BITE 9 0.0012
556 IMMUNE SYSTEM DISORDER 16 0.0012
557 RASH ERYTHEMATOUS 58 0.0012
558 BRAIN FOG 19 0.0012
559 SEIZURE 140 0.0012
560 GENERALISED OEDEMA 15 0.0012
561 VENTRICULAR TACHYCARDIA 20 0.0012
562 BLOOD PRESSURE ABNORMAL 24 0.0012
563 ILEUS 15 0.0012
564 PRODUCT USE COMPLAINT 19 0.0012
565 DRY EYE 60 0.0012
566 EOSINOPHIL COUNT INCREASED 10 0.0012
567 HEPATOCELLULAR INJURY 17 0.0012
568 EYELID PTOSIS 12 0.0012
569 ATAXIA 14 0.0012
570 DENTAL CARIES 13 0.0012
571 MYOCLONUS 14 0.0012
572 FLANK PAIN 11 0.0012
573 HYPOKALAEMIA 54 0.0012
574 NEUROPATHY PERIPHERAL 111 0.0012
575 MATERNAL EXPOSURE DURING PREGNANCY 104 0.0012
576 VISION BLURRED 160 0.0012
577 ILLNESS 120 0.0012
578 TENDONITIS 18 0.0012
579 FOOT FRACTURE 22 0.0012
580 SKIN INFECTION 13 0.0012
581 EPISTAXIS 86 0.0011
582 SUPRAVENTRICULAR TACHYCARDIA 11 0.0011
583 THROAT TIGHTNESS 31 0.0011
584 CHOLESTASIS 22 0.0011
585 OSTEOPOROSIS 47 0.0011
586 DIABETES MELLITUS 87 0.0011
587 CHOLECYSTECTOMY 13 0.0011
588 SCRATCH 12 0.0011
589 THERAPY NON-RESPONDER 51 0.0011
590 HYPERCALCAEMIA 14 0.0011
591 PRODUCT COMMUNICATION ISSUE 10 0.0011
592 SKIN LESION 31 0.0011
593 HAEMORRHOIDS 22 0.0011
594 BODY TEMPERATURE INCREASED 23 0.0011
595 CARDIAC ARREST 92 0.0011
596 IMPAIRED QUALITY OF LIFE 16 0.0011
597 HEART RATE DECREASED 39 0.0011
598 MUSCLE ATROPHY 14 0.0011
599 LIMB INJURY 30 0.0011
600 COVID-19 PNEUMONIA 13 0.0011
601 SALIVARY HYPERSECRETION 11 0.0011
602 OESOPHAGITIS 12 0.0011
603 HYPERGLYCAEMIA 40 0.0011
604 PHOTOSENSITIVITY REACTION 18 0.0011
605 TOOTH FRACTURE 12 0.0011
606 TASTE DISORDER 22 0.0011
607 AGEUSIA 27 0.0011
608 RETCHING 23 0.0011
609 FEELING COLD 30 0.0011
610 LYMPHADENOPATHY 38 0.0011
611 PULMONARY OEDEMA 48 0.0011
612 EAR DISCOMFORT 11 0.0011
613 PRODUCT DOSE OMISSION ISSUE 315 0.0011
614 APPENDICITIS 10 0.0011
615 CYTOPENIA 13 0.0011
616 LEUKOPENIA 53 0.0011
617 INCREASED APPETITE 20 0.0010
618 GASTRIC HAEMORRHAGE 12 0.0010
619 BLOOD MAGNESIUM DECREASED 9 0.0010
620 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 74 0.0010
621 HYPOTENSION 208 0.0010
622 PULMONARY ARTERIAL HYPERTENSION 15 0.0010
623 DEHYDRATION 138 0.0010
624 PRODUCT TASTE ABNORMAL 14 0.0010
625 BLOOD POTASSIUM DECREASED 31 0.0010
626 FLUID OVERLOAD 15 0.0010
627 SPEECH DISORDER 54 0.0010
628 EAR PAIN 20 0.0010
629 CHILLS 120 0.0010
630 HAEMATURIA 35 0.0010
631 INFLUENZA LIKE ILLNESS 84 0.0010
632 DECREASED IMMUNE RESPONSIVENESS 10 0.0010
633 HEART RATE IRREGULAR 23 0.0010
634 INTERNATIONAL NORMALISED RATIO INCREASED 29 0.0010
635 HYPOPHAGIA 26 0.0010
636 INFUSION SITE PAIN 13 0.0010
637 CHOLELITHIASIS 33 0.0010
638 HYPOMAGNESAEMIA 14 0.0010
639 ABDOMINAL PAIN UPPER 207 0.0010
640 HYPERLIPIDAEMIA 12 0.0010
641 UPPER LIMB FRACTURE 20 0.0010
642 MASS 14 0.0010
643 ELECTROCARDIOGRAM QT PROLONGED 36 0.0010
644 METABOLIC ACIDOSIS 32 0.0010
645 NEUTROPENIA 136 0.0010
646 DECREASED APPETITE 232 0.0010
647 LIVER FUNCTION TEST ABNORMAL 29 0.0010
648 PLATELET COUNT INCREASED 13 0.0010
649 MOUTH ULCERATION 21 0.0010
650 ADRENAL INSUFFICIENCY 12 0.0010
651 PAIN IN JAW 28 0.0010
652 NECK PAIN 55 0.0010
653 PANCREATITIS 52 0.0010
654 COVID-19 172 0.0010
655 DELIRIUM 34 0.0010
656 ANAPHYLACTIC REACTION 54 0.0010
657 VISUAL IMPAIRMENT 121 0.0010
658 VERTIGO 59 0.0010
659 ANOSMIA 14 0.0010
660 RASH GENERALISED 25 0.0010
661 VENTRICULAR EXTRASYSTOLES 10 0.0010
662 DRUG ERUPTION 17 0.0010
663 ARTERIOSCLEROSIS 9 0.0010
664 PALLOR 26 0.0010
665 CONSTIPATION 208 0.0010
666 TOXICITY TO VARIOUS AGENTS 160 0.0009
667 ABDOMINAL DISTENSION 99 0.0009
668 HAEMATEMESIS 24 0.0009
669 BLOOD LACTATE DEHYDROGENASE INCREASED 15 0.0009
670 INCONTINENCE 10 0.0009
671 SLEEP APNOEA SYNDROME 18 0.0009
672 ABDOMINAL PAIN 219 0.0009
673 ORAL DISCOMFORT 13 0.0009
674 HAEMOGLOBIN DECREASED 96 0.0009
675 SCAR 16 0.0009
676 FEAR 25 0.0009
677 HIATUS HERNIA 12 0.0009
678 BLINDNESS UNILATERAL 13 0.0009
679 SWELLING FACE 60 0.0009
680 JOINT SWELLING 111 0.0009
681 LYMPHOPENIA 13 0.0009
682 PRODUCT DISPENSING ERROR 20 0.0009
683 PULMONARY EMBOLISM 87 0.0009
684 RASH MACULAR 32 0.0009
685 URINARY TRACT INFECTION 156 0.0009
686 BALANCE DISORDER 79 0.0009
687 BLOOD GLUCOSE FLUCTUATION 10 0.0009
688 LOCALISED INFECTION 22 0.0009
689 NEURALGIA 22 0.0009
690 RASH PRURITIC 49 0.0009
691 DISEASE RECURRENCE 43 0.0009
692 PARAESTHESIA ORAL 13 0.0009
693 HEADACHE 565 0.0009
694 INJURY 63 0.0009
695 GASTRIC ULCER 17 0.0009
696 SPINAL OPERATION 11 0.0009
697 EATING DISORDER 19 0.0009
698 FISTULA 10 0.0009
699 URTICARIA 149 0.0009
700 DISEASE PROGRESSION 105 0.0009
701 CYST 11 0.0009
702 OEDEMA 48 0.0009
703 DYSPEPSIA 87 0.0009
704 ATRIAL FIBRILLATION 86 0.0009
705 MEDICATION ERROR 49 0.0009
706 HIP FRACTURE 28 0.0009
707 HYPONATRAEMIA 49 0.0009
708 MUSCULOSKELETAL STIFFNESS 76 0.0009
709 BACK PAIN 201 0.0009
710 PREMATURE BABY 26 0.0009
711 HYPOAESTHESIA ORAL 13 0.0009
712 MUSCULOSKELETAL PAIN 45 0.0009
713 LYMPHOCYTE COUNT DECREASED 15 0.0008
714 MIGRAINE 81 0.0008
715 FLATULENCE 48 0.0008
716 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 60 0.0008
717 ANXIETY 240 0.0008
718 CHROMATURIA 19 0.0008
719 BODY HEIGHT DECREASED 9 0.0008
720 PRODUCT ADMINISTRATION ERROR 17 0.0008
721 LIP SWELLING 28 0.0008
722 CHOLECYSTITIS 10 0.0008
723 DYSGEUSIA 62 0.0008
724 DEPRESSED MOOD 44 0.0008
725 BACK INJURY 9 0.0008
726 VOMITING 388 0.0008
727 BURSITIS 10 0.0008
728 RASH 359 0.0008
729 CIRCULATORY COLLAPSE 14 0.0008
730 FATIGUE 640 0.0008
731 DEPRESSION 187 0.0008
732 CEREBRAL INFARCTION 20 0.0008
733 OBESITY 13 0.0008
734 CARDIO-RESPIRATORY ARREST 34 0.0008
735 WEIGHT INCREASED 182 0.0008
736 INCORRECT ROUTE OF DRUG ADMINISTRATION 29 0.0008
737 TENDON RUPTURE 10 0.0008
738 NIGHTMARE 28 0.0008
739 DIARRHOEA 521 0.0008
740 CONVULSION 46 0.0008
741 RASH PAPULAR 18 0.0008
742 DEVICE USE ISSUE 14 0.0008
743 BLOOD CREATINE PHOSPHOKINASE INCREASED 23 0.0008
744 HEPATIC CIRRHOSIS 15 0.0008
745 RESPIRATORY ARREST 22 0.0008
746 RECTAL HAEMORRHAGE 34 0.0008
747 COLITIS 30 0.0008
748 EXPOSURE DURING PREGNANCY 49 0.0008
749 BONE MARROW FAILURE 16 0.0008
750 GASTRIC DISORDER 27 0.0008
751 FAECES DISCOLOURED 17 0.0008
752 CYTOMEGALOVIRUS INFECTION 13 0.0008
753 PHARYNGEAL OEDEMA 12 0.0008
754 INTERVERTEBRAL DISC PROTRUSION 17 0.0008
755 ASTHENIA 292 0.0008
756 HERNIA 15 0.0008
757 UPPER GASTROINTESTINAL HAEMORRHAGE 13 0.0008
758 DEEP VEIN THROMBOSIS 50 0.0008
759 INTENTIONAL PRODUCT USE ISSUE 67 0.0008
760 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 14 0.0008
761 FEELING ABNORMAL 183 0.0008
762 APHASIA 23 0.0008
763 IMPAIRED HEALING 25 0.0008
764 ACCIDENT 9 0.0008
765 INCORRECT PRODUCT ADMINISTRATION DURATION 16 0.0007
766 MUSCLE TWITCHING 17 0.0007
767 DIPLOPIA 19 0.0007
768 METASTASES TO BONE 12 0.0007
769 GLAUCOMA 14 0.0007
770 ANGIOEDEMA 32 0.0007
771 GASTRITIS 19 0.0007
772 HYPOGLYCAEMIA 35 0.0007
773 DISCOMFORT 44 0.0007
774 HEPATOTOXICITY 16 0.0007
775 NO ADVERSE EVENT 130 0.0007
776 BRADYCARDIA 38 0.0007
777 PRODUCT PRESCRIBING ERROR 17 0.0007
778 LYMPHOMA 11 0.0007
779 ACCIDENTAL OVERDOSE 26 0.0007
780 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 128 0.0007
781 LACTIC ACIDOSIS 23 0.0007
782 CONTUSION 68 0.0007
783 PRODUCT AVAILABILITY ISSUE 16 0.0007
784 PARALYSIS 10 0.0007
785 BLISTER 39 0.0007
786 NAUSEA 549 0.0007
787 CYSTITIS 22 0.0007
788 PREMATURE DELIVERY 11 0.0007
789 HAEMORRHAGE 72 0.0007
790 C-REACTIVE PROTEIN INCREASED 25 0.0007
791 OSTEONECROSIS OF JAW 17 0.0007
792 FEELING JITTERY 13 0.0007
793 DIZZINESS 340 0.0007
794 WOUND 19 0.0007
795 DRUG DOSE OMISSION 112 0.0007
796 BLOOD PRESSURE DECREASED 45 0.0007
797 STOMATITIS 41 0.0007
798 TOOTH DISORDER 15 0.0007
799 DYSPHAGIA 64 0.0007
800 ARTHRITIS 53 0.0007
801 HEPATIC FUNCTION ABNORMAL 25 0.0007
802 JAUNDICE 18 0.0007
803 ARTHROPATHY 37 0.0007
804 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
805 DRUG INEFFECTIVE 875 0.0007
806 TOOTHACHE 12 0.0007
807 HERPES ZOSTER 38 0.0007
808 BLOOD PRESSURE INCREASED 101 0.0007
809 OSTEOARTHRITIS 28 0.0007
810 MOOD SWINGS 21 0.0007
811 PANIC ATTACK 24 0.0007
812 SKIN ULCER 17 0.0007
813 ERYTHEMA 134 0.0007
814 ABORTION SPONTANEOUS 26 0.0006
815 THROMBOSIS 52 0.0006
816 PRODUCT PRESCRIBING ISSUE 14 0.0006
817 MIDDLE INSOMNIA 12 0.0006
818 SWOLLEN TONGUE 20 0.0006
819 ANAEMIA 122 0.0006
820 ABDOMINAL DISCOMFORT 107 0.0006
821 DRUG-INDUCED LIVER INJURY 20 0.0006
822 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
823 ADVERSE DRUG REACTION 57 0.0006
824 PERIPHERAL SWELLING 97 0.0006
825 FREQUENT BOWEL MOVEMENTS 17 0.0006
826 SEROTONIN SYNDROME 12 0.0006
827 LOWER LIMB FRACTURE 12 0.0006
828 HOT FLUSH 47 0.0006
829 EMOTIONAL DISORDER 19 0.0006
830 SKIN DISCOLOURATION 28 0.0006
831 HYPERTENSION 129 0.0006
832 PAIN 374 0.0006
833 PELVIC PAIN 11 0.0006
834 OEDEMA PERIPHERAL 73 0.0006
835 IRRITABILITY 36 0.0006
836 ROAD TRAFFIC ACCIDENT 25 0.0006
837 THERAPEUTIC RESPONSE DECREASED 36 0.0006
838 AGRANULOCYTOSIS 11 0.0006
839 COMA 28 0.0006
840 SWELLING 55 0.0006
841 AGITATION 43 0.0006
842 CARDIAC FAILURE 47 0.0006
843 CONFUSIONAL STATE 94 0.0006
844 ANKLE FRACTURE 9 0.0006
845 RHEUMATOID ARTHRITIS 66 0.0006
846 SKIN EXFOLIATION 49 0.0006
847 TOOTH LOSS 12 0.0006
848 MENTAL IMPAIRMENT 14 0.0006
849 URINARY INCONTINENCE 17 0.0006
850 HALLUCINATION, VISUAL 12 0.0006
851 HEAD DISCOMFORT 10 0.0006
852 HEPATIC FAILURE 17 0.0006
853 CARDIAC FAILURE CONGESTIVE 45 0.0006
854 RED BLOOD CELL COUNT DECREASED 16 0.0006
855 INSOMNIA 148 0.0006
856 MEMORY IMPAIRMENT 76 0.0006
857 ARRHYTHMIA 26 0.0005
858 SPINAL FRACTURE 11 0.0005
859 FEMUR FRACTURE 17 0.0005
860 MUSCULAR WEAKNESS 62 0.0005
861 EMOTIONAL DISTRESS 66 0.0005
862 BLOOD GLUCOSE DECREASED 26 0.0005
863 ARTHRALGIA 225 0.0005
864 ORAL PAIN 12 0.0005
865 HYPOTHYROIDISM 17 0.0005
866 FALL 177 0.0005
867 PRURITUS 204 0.0005
868 INFUSION RELATED REACTION 35 0.0005
869 RHABDOMYOLYSIS 22 0.0005
870 POLLAKIURIA 22 0.0005
871 BLOOD URINE PRESENT 10 0.0005
872 DRUG ADMINISTRATION ERROR 16 0.0005
873 RESTLESSNESS 19 0.0005
874 DRY SKIN 69 0.0005
875 CARDIAC DISORDER 48 0.0005
876 IRRITABLE BOWEL SYNDROME 11 0.0005
877 GAIT DISTURBANCE 98 0.0005
878 MYALGIA 87 0.0005
879 POOR QUALITY SLEEP 11 0.0005
880 BONE DENSITY DECREASED 16 0.0005
881 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
882 PLATELET COUNT DECREASED 54 0.0005
883 HEAD INJURY 16 0.0005
884 DEPRESSED LEVEL OF CONSCIOUSNESS 20 0.0005
885 ABNORMAL BEHAVIOUR 20 0.0005
886 DYSARTHRIA 19 0.0005
887 SOMNOLENCE 101 0.0005
888 CYTOKINE RELEASE SYNDROME 10 0.0005
889 MOVEMENT DISORDER 16 0.0005
890 CRYING 18 0.0005
891 DRY MOUTH 40 0.0005
892 AMNESIA 32 0.0005
893 FLUID RETENTION 25 0.0005
894 MUSCLE SPASMS 90 0.0005
895 HYPERHIDROSIS 63 0.0005
896 LIVER INJURY 12 0.0005
897 PRODUCT PREPARATION ERROR 10 0.0005
898 NERVOUS SYSTEM DISORDER 15 0.0005
899 UNDERDOSE 35 0.0005
900 DISORIENTATION 19 0.0005
901 PAIN IN EXTREMITY 141 0.0005
902 MOOD ALTERED 13 0.0005
903 INTERSTITIAL LUNG DISEASE 23 0.0005
904 PSYCHOTIC DISORDER 14 0.0005
905 ANGER 16 0.0005
906 DIVERTICULITIS 13 0.0005
907 HEPATITIS 12 0.0005
908 PRODUCT STORAGE ERROR 41 0.0005
909 JOINT INJURY 10 0.0005
910 NEUTROPHIL COUNT DECREASED 19 0.0005
911 BLOOD PRESSURE FLUCTUATION 11 0.0005
912 MELAENA 10 0.0005
913 WHITE BLOOD CELL COUNT DECREASED 49 0.0005
914 SYNCOPE 45 0.0004
915 URINARY RETENTION 15 0.0004
916 DISTURBANCE IN ATTENTION 24 0.0004
917 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 13 0.0004
918 ACUTE MYOCARDIAL INFARCTION 13 0.0004
919 GLYCOSYLATED HAEMOGLOBIN INCREASED 11 0.0004
920 HAEMATOCHEZIA 24 0.0004
921 GASTROINTESTINAL HAEMORRHAGE 36 0.0004
922 DERMATITIS 9 0.0004
923 CORONARY ARTERY DISEASE 13 0.0004
924 OSTEONECROSIS 14 0.0004
925 HYPOAESTHESIA 63 0.0004
926 ECZEMA 22 0.0004
927 LIMB DISCOMFORT 13 0.0004
928 SKIN DISORDER 14 0.0004
929 JOINT STIFFNESS 11 0.0004
930 PALPITATIONS 49 0.0004
931 FOETAL EXPOSURE DURING PREGNANCY 34 0.0004
932 MYELOSUPPRESSION 15 0.0004
933 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 14 0.0004
934 DEVICE MALFUNCTION 29 0.0004
935 INTENTIONAL PRODUCT MISUSE 36 0.0004
936 BLOOD GLUCOSE INCREASED 77 0.0004
937 DYSURIA 15 0.0004
938 INCORRECT DOSE ADMINISTERED 93 0.0004
939 CEREBROVASCULAR ACCIDENT 69 0.0004
940 ALOPECIA 79 0.0004
941 TREMOR 66 0.0004
942 CEREBRAL HAEMORRHAGE 14 0.0004
943 NEOPLASM MALIGNANT 26 0.0004
944 HAEMATOMA 10 0.0004
945 HALLUCINATION 29 0.0004
946 PARAESTHESIA 60 0.0004
947 AGGRESSION 19 0.0004
948 DYSSTASIA 11 0.0004
949 FLUSHING 38 0.0004
950 ABASIA 9 0.0004
951 DEMENTIA 10 0.0004
952 INCORRECT DRUG ADMINISTRATION DURATION 10 0.0004
953 CARDIOVASCULAR DISORDER 9 0.0004
954 ANGINA PECTORIS 10 0.0003
955 EXTRA DOSE ADMINISTERED 14 0.0003
956 DYSKINESIA 14 0.0003
957 LOSS OF CONSCIOUSNESS 44 0.0003
958 ACNE 26 0.0003
959 BONE PAIN 20 0.0003
960 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
961 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
962 GAIT INABILITY 11 0.0003
963 EPILEPSY 10 0.0003
964 ADVERSE EVENT 30 0.0003
965 DEVICE ISSUE 28 0.0003
966 FEELING HOT 19 0.0003
967 SUICIDAL IDEATION 27 0.0003
968 NERVOUSNESS 15 0.0003
969 PRODUCT QUALITY ISSUE 38 0.0003
970 PRODUCT SUBSTITUTION ISSUE 16 0.0003
971 DEVICE DISLOCATION 12 0.0003
972 BURNING SENSATION 19 0.0003
973 LUNG NEOPLASM MALIGNANT 11 0.0003
974 DERMATITIS ATOPIC 14 0.0003
975 PROSTATE CANCER 21 0.0003
976 VAGINAL HAEMORRHAGE 11 0.0003
977 MOBILITY DECREASED 18 0.0003
978 INJECTION SITE SWELLING 19 0.0002
979 BLOOD CHOLESTEROL INCREASED 11 0.0002
980 COGNITIVE DISORDER 11 0.0002
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 11 0.0002
982 MYOCARDIAL INFARCTION 40 0.0002
983 OVERDOSE 43 0.0002
984 ACCIDENTAL EXPOSURE TO PRODUCT 20 0.0002
985 INJECTION SITE ERYTHEMA 21 0.0002
986 SUICIDE ATTEMPT 10 0.0002
987 DEVICE DIFFICULT TO USE 10 0.0002
988 BREAST CANCER 14 0.0002
989 MALIGNANT NEOPLASM PROGRESSION 15 0.0001
990 INJECTION SITE PAIN 35 0.0001
991 DRUG DEPENDENCE 15 0.0001
992 PSORIASIS 10 0.0001